Development and preclinical evaluation of radioligands for the PET studies of cerebral adenosine A1 and A2A receptors by Shivashankar, Shivashankar
  
 University of Groningen
Development and preclinical evaluation of radioligands for the PET studies of cerebral
adenosine A1 and A2A receptors
Shivashankar, Shivashankar
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2014
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Shivashankar, S. (2014). Development and preclinical evaluation of radioligands for the PET studies of
cerebral adenosine A1 and A2A receptors. [S.l.]: [S.n.].
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Propositions 
belonging to the thesis 
“Development and Preclinical Evaluation of Radioligands for the PET Studies of  
Cerebral Adenosine A1 and A2A Receptors” 
Shivashankar 
1. PET is a sensitive, non-invasive in vivo imaging technique for quantitative 
measurements of biochemical processes but specificity of a radioligand for a single, 
unique target (or biochemical process) may be hard to prove (Chapter 3, 4, and 6 of this 
thesis). 
2. As the length of the fluoroalkyl chain of SCH442416 derivative increases (from methyl to 
fluoropropyl), tracer uptake in skull bone also increases. (Chapter 3 of this thesis)  
3. Even though preladenant failed to demonstrate clinical efficacy in phase III studies for 
the treatment of Parkinson’s disease, its properties (subtype selectivity, high affinity, 
regional distribution in brain) could still make it a potential PET tracer for in vivo 
imaging of cerebral A2ARs – although its slow kinetics results in long scanning times. 
(Chapter 4 of this thesis) 
4. Increases of the cerebral uptake of the adenosine A1 receptor ligand [11C]MPDX after 
treatment of rodents with ethanol and an adenosine kinase inhibitor (chapter 6) or N6-
cyclopentyl adenosine (Paul et al., 2014) may be due to the fact that the radiotracer is an 
inverse agonist. 
5. Since the negative findings of chapter 5 could either be due to failure of the blood-brain 
barrier to open after an adenosinergic stimulus in anesthetized rats or to inappropriate 
kinetics of the tested tracer, further studies with RatCap tomograph-which allow 
molecular imaging of rodent brain in the awake condition – is highly relevant (Baba. JS 
et al. J Nucl Med.2013; 54:969-976 and Schulz. D et al. Nat. Methods. 2011; 8:347-352)  
6. “Gold standard” does not have to be necessarily the “truth”: it can include known or 
unknown systematic errors, as long as the same errors exist in the results that are going 
to be compared with the gold standard. 
7. In the Netherlands, you are super lucky if you have two things for a long time: your bike 
and sunny weather. 
8. The mind is beautiful, but thoughts decide to what degree. 
9. A man is known by the company he keeps. 
10. To increase the productivity in science, brainstorm as much as you can, and only test the 
most probable ideas. You may miss the possibility of the rare accidental discovery, but 
your approach is more logical than being dependent on pure luck. 
11. “Arise, awake and stop not till the goal is reached”- Swami Vivekananda (Great Indian 
Philosopher) 
12. “You must be the change you wish to see in the world”- Mahatma Gandhi (Father of the 
Indian nation) 
 
